Navigation Links
Novartis Vaccines to Host Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers
Date:11/13/2007

t the disease in 100 percent of individuals.

"By offering on-site influenza vaccination clinics at Simon Malls, we are providing an easily accessible way for our shoppers to help protect themselves during the peak influenza season," said Candis Montgomery, Regional Director of Business Development, Northgate Mall. "We are pleased to team with Novartis Vaccines and RediClinic to present this added convenience to our patrons during the busy holiday season."

About the Northgate Mall Influenza Vaccination Clinic

The Northgate Mall influenza vaccination clinic, sponsored by Novartis Vaccines, in partnership with Public Health - Seattle & King County and RediClinic, is designed to help support the CDC's efforts to extend the vaccination season, and to increase vaccination rates to reduce illness and deaths from influenza and its complications.

Influenza vaccine is a regulated product; its availability may be restricted or curtailed. The local influenza vaccination clinic will comply with all national, state, and local health regulations.

To find additional influenza vaccination clinics if you are unable to attend the clinic at Northgate Mall, visit http://www.metrokc.gov/health/immunization/fluseason.htm or call Public Health's Information Line at 206-296-4949. For more information about how to help prevent influenza, consumers may visit http://www.FluSource.com.

About Influenza

Influenza is a contagious disease of the respiratory tract (nose, throat, and lungs) that can lead to serious complications, such as pneumonia and dehydration, and worsening of chronic medical conditions, such as congestive heart failure, asthma, or diabetes.

Many people confuse influenza with the common cold, but, in fact, influenza can be a much more serious illness. An average of about 36,000 US residents die ea
'/>"/>

SOURCE Novartis Vaccines
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Novartis Vaccines Launches National Gift-Giving Program to Help Protect Loved Ones by Reserving an Influenza Vaccination
2. Colorado Influenza and Pneumococcal Alert Coalition (CIPAC) Partners with Novartis Vaccines for Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers
3. Novartis Vaccines Partners With RediClinic for Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers
4. Human Papilloma Virus vaccines may decrease chances of oral cancer
5. CDC Study Links Thimerosal in Vaccines to Motor/Phonic Tics and Deficits in Attention, Behavior Control, Verbal IQ
6. Combination vaccines okay for infants, study shows
7. Leave That Holiday To Do List in a Drawer
8. American Council on Exercise Offers 10 Tips for Surviving the Holidays
9. Make a Difference This Holiday Season
10. Marriage & Family: Celebrating Holiday Traditions
11. Have a Heart-Healthy Holiday
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)..., study suggests , , THURSDAY, Jan. 8 (...rongly they would react to racist acts, a new Cana...y participants at York University, in Toronto, sti... person rather than a black one, even after their ...rson when he left the room. , "And the racist...
(Date:1/8/2009).../ -- Allscripts-Misys Healthcare,Solutions, Inc.,...llscripts or,the Company), today announced its fi...d November 30, 2008. , (Logo: http://www.n...) , The Company,s results for the three and...ts from legacy Allscripts for the period of Octobe...
(Date:1/8/2009)...wire/ -- A new educational Web site offers expert ...ical products and medical devices from the Agency ...Education and Research on Therapeutics (CERTs), a ...eading research centers nationwide. The Clinician...AIN ) http://www.chainonline.org links clinician...
(Date:1/8/2009)...Call/ -- Heska Corporation (Nasdaq: HSKA ) annou... Heska Corporation Invites You to Join Its Fourth... Conference Call on the Web, When: Monda... www.heska.com (click on the Q4 and Year-End 200...age of this website)., How: Live over t...
Breaking Medicine News(10 mins):Health News:Many Turn Blind Eye to Racism 2Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 2Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 3Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 4Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 5Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 6Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 7Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 8Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 9Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 10Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 11Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 12Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 13Health News:AHRQ Announces New Web Site on Emerging Issues in Medical Therapeutics 2Health News:Webcast Alert: Heska Announces Fourth Quarter and Year-End 2008 Earnings Conference Call Webcast 2
...esearchers say eating fish could help keep ones mi... high intake of cholesterol and saturated fat have...middle age. More and more research is showing what... for dementia. For example, studies have shown tha...
... risk factor, which accounts for about half of the...e is now a more dependable, less expensive test to... the NMP22 tumor marker assay in 1,331 patients at...s found that of the 79 patients shown to have blad...
...ound in the air in many inner-city homes could be ...n children say researchers. According to researche...ously exposed to the allergy-causing substance fou... the air and exposure increases their risk for dev...
...sted early onset wheezing is associated with high ...d bronchial hyper-responsiveness. Children with th... more severe asthma. However, some children who de...ith the same characteristics as those who begin wh...
Other Medicine News:
(Date:1/7/2009)... ImQuest Life Sciences announced today the success...nd Drug Administration to initiate human clinical ...r IQP-0410. ImQuest anticipates initiating their P...410 is a novel small molecule inhibitor of HIV whi...criptase inhibitor (NNRTI). The compound possesses...
(Date:1/6/2009)...from prior U.S., U.K. and China Trials , , SAN .... (VTI), a development stage company targeting liv... begun for a randomized, controlled, multi-center,...orporeal Liver Assist Device (ELAD) as a treatment... three protocols. The study is open for enrollment...
(Date:1/6/2009)...ewswire/ -- Sequella, Inc., a clinical-stage bioph...ic potential, announced today that SQ109, its lead...(TB), was the first drug approved for evaluation i...port Vaccine Company LLC and Quintiles Transnation...e of Allergy and Infectious Diseases (NIAID), Nati...
(Date:1/5/2009)...ne Pharmaceuticals announced today that it has ini...otein kinase inhibitor, CX-4945, in patients with ...tiple myeloma. The primary endpoints of the oral d...tolerance and PK properties of CX-4945 and to sele...dition, multiple mechanism-related pharmacodynamic...
Breaking Medicine Technology:ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 3Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 2Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 3Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 2Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard 28TM 29 in The U S 3500 1PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard 28TM 29 in The U S 3500 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard 28TM 29 in The U S 3500 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard 28TM 29 in The U S 3500 4China Nepstar Chain Drugstore Reports Third Quarter 2008 Results 30671 1China Nepstar Chain Drugstore Reports Third Quarter 2008 Results 30671 2China Nepstar Chain Drugstore Reports Third Quarter 2008 Results 30671 3China Nepstar Chain Drugstore Reports Third Quarter 2008 Results 30671 4China Nepstar Chain Drugstore Reports Third Quarter 2008 Results 30671 5China Nepstar Chain Drugstore Reports Third Quarter 2008 Results 30671 6China Nepstar Chain Drugstore Reports Third Quarter 2008 Results 30671 7China Nepstar Chain Drugstore Reports Third Quarter 2008 Results 30671 8China Nepstar Chain Drugstore Reports Third Quarter 2008 Results 30671 9China Nepstar Chain Drugstore Reports Third Quarter 2008 Results 30671 10China Nepstar Chain Drugstore Reports Third Quarter 2008 Results 30671 11Sentillion Appoints New UK Sales Manager 30669 1Sentillion Appoints New UK Sales Manager 30669 2Lt Col Weinstein New Book 3A Universal Health Care Will Not Work Unless 30664 1Lt Col Weinstein New Book 3A Universal Health Care Will Not Work Unless 30664 2Lt Col Weinstein New Book 3A Universal Health Care Will Not Work Unless 30664 3Lt Col Weinstein New Book 3A Universal Health Care Will Not Work Unless 30664 4
...-- Shire plc,announced today the positive results ...acine extended release (GXR,previously referred t...onist. These data from two short-term phase,III pl...II,open-label studies, presented at the 2007 Ameri...demonstrated that GXR,significantly improved all c...
...onoclonal Antibody,Targeting Interleukin-9 (IL-9);...-9 Inhibition in Developing Potential Asthma,Thera...FirstCall/ --,MedImmune, Inc. today announced the ...within the company,s inflammatory,disease pipeline...ies with its monoclonal antibody (MAb) targeting I...
Other Medicine Technology:Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 2Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 3Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 4Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 5Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 6Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 7Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 8MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 2MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 3MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 4MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 5MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 6MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 7
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
Medicine Products: